FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2780680405> ?p ?o ?g. }

• W2780680405 endingPage "397" @default.
• W2780680405 startingPage "391" @default.
• W2780680405 abstract "Purpose To determine obligate overdiagnosis rates, defined as the percentage of women diagnosed with screen-detected breast cancer who die of causes other than breast cancer prior to clinical presentation of that cancer, for ductal carcinoma in situ (DCIS), invasive breast cancer, and all breast cancers. Materials and Methods Age-specific all-cause mortality rates from the Human Mortality Database, age-specific breast cancer incidence and mortality rates from Surveillance, Epidemiology, and End Results data, and estimates of mean lead times and lead time distributions from breast cancer screening trials are used to estimate obligate (or type 1) overdiagnosis rates for DCIS, invasive breast cancer, and all breast cancers (DCIS plus invasive) for U.S. women undergoing screening mammography. Mortality rates by age are used to estimate the number of women who die of causes other than breast cancer during the lead time afforded by screening mammography. Resulting age-dependent overdiagnosis rates, along with screen-detected breast cancer incidence by age, are used to estimate type 1 overdiagnosis rates for the U.S. screening population. Results Obligate overdiagnosis rates depend strongly on the age at which a woman is screened, ranging from less than 1% at age 40 years to 30%, 21%, and 22.5% at age 80 years for DCIS, invasive breast cancer, and all breast cancers, respectively. Type 1 overdiagnosis rates among screened women in the United States are estimated to be 9% for DCIS and approximately 7% for both invasive breast cancer and all breast cancers. Screening of women ages 40–49 years (or premenopausal women, as determined from patient history, starting at age 40 years) adds little to obligate overdiagnosis rates (0.15% for DCIS and less than 0.1% for invasive breast cancer and all breast cancers). Conclusion Type 1 overdiagnosis rates increase rapidly with age at screening. Obligate overdiagnosis occurs in 9% of DCIS and approximately 7% of both invasive breast cancer and all breast cancers in the U.S. mammographic screening population, with screening of women ages 40–49 years (or premenopausal women starting at age 40 years) making a negligible contribution of 0.15% to obligate overdiagnosis of DCIS and a contribution of less than 0.1% to the obligate overdiagnosis rates of invasive breast cancer and all breast cancers. © RSNA, 2017 Online supplemental material is available for this article." @default.
• W2780680405 created "2018-01-05" @default.
• W2780680405 creator A5027672505 @default.
• W2780680405 date "2018-05-01" @default.
• W2780680405 modified "2023-10-16" @default.
• W2780680405 title "Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women" @default.
• W2780680405 cites W1921869839 @default.
• W2780680405 cites W1975775651 @default.
• W2780680405 cites W1975847372 @default.
• W2780680405 cites W1979025652 @default.
• W2780680405 cites W1988130046 @default.
• W2780680405 cites W1988828013 @default.
• W2780680405 cites W2020046511 @default.
• W2780680405 cites W2039821491 @default.
• W2780680405 cites W2063338680 @default.
• W2780680405 cites W2064813514 @default.
• W2780680405 cites W2075189774 @default.
• W2780680405 cites W2082036875 @default.
• W2780680405 cites W2087434646 @default.
• W2780680405 cites W2088361920 @default.
• W2780680405 cites W2096166071 @default.
• W2780680405 cites W2099644906 @default.
• W2780680405 cites W2109596058 @default.
• W2780680405 cites W2110934031 @default.
• W2780680405 cites W2113622720 @default.
• W2780680405 cites W2130121448 @default.
• W2780680405 cites W2137584842 @default.
• W2780680405 cites W2148309496 @default.
• W2780680405 cites W2149058532 @default.
• W2780680405 cites W2169666080 @default.
• W2780680405 cites W2171544511 @default.
• W2780680405 cites W2264964449 @default.
• W2780680405 cites W2283351472 @default.
• W2780680405 cites W2593604283 @default.
• W2780680405 cites W2609152131 @default.
• W2780680405 cites W4233025294 @default.
• W2780680405 doi "https://doi.org/10.1148/radiol.2017171622" @default.
• W2780680405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29267146" @default.
• W2780680405 hasPublicationYear "2018" @default.
• W2780680405 type Work @default.
• W2780680405 sameAs 2780680405 @default.
• W2780680405 citedByCount "24" @default.
• W2780680405 countsByYear W27806804052018 @default.
• W2780680405 countsByYear W27806804052019 @default.
• W2780680405 countsByYear W27806804052020 @default.
• W2780680405 countsByYear W27806804052021 @default.
• W2780680405 countsByYear W27806804052022 @default.
• W2780680405 countsByYear W27806804052023 @default.
• W2780680405 crossrefType "journal-article" @default.
• W2780680405 hasAuthorship W2780680405A5027672505 @default.
• W2780680405 hasConcept C107130276 @default.
• W2780680405 hasConcept C120665830 @default.
• W2780680405 hasConcept C121332964 @default.
• W2780680405 hasConcept C121608353 @default.
• W2780680405 hasConcept C126322002 @default.
• W2780680405 hasConcept C131872663 @default.
• W2780680405 hasConcept C143998085 @default.
• W2780680405 hasConcept C2778491387 @default.
• W2780680405 hasConcept C2779377019 @default.
• W2780680405 hasConcept C2780472235 @default.
• W2780680405 hasConcept C2908647359 @default.
• W2780680405 hasConcept C29456083 @default.
• W2780680405 hasConcept C530470458 @default.
• W2780680405 hasConcept C61511704 @default.
• W2780680405 hasConcept C71924100 @default.
• W2780680405 hasConcept C99454951 @default.
• W2780680405 hasConceptScore W2780680405C107130276 @default.
• W2780680405 hasConceptScore W2780680405C120665830 @default.
• W2780680405 hasConceptScore W2780680405C121332964 @default.
• W2780680405 hasConceptScore W2780680405C121608353 @default.
• W2780680405 hasConceptScore W2780680405C126322002 @default.
• W2780680405 hasConceptScore W2780680405C131872663 @default.
• W2780680405 hasConceptScore W2780680405C143998085 @default.
• W2780680405 hasConceptScore W2780680405C2778491387 @default.
• W2780680405 hasConceptScore W2780680405C2779377019 @default.
• W2780680405 hasConceptScore W2780680405C2780472235 @default.
• W2780680405 hasConceptScore W2780680405C2908647359 @default.
• W2780680405 hasConceptScore W2780680405C29456083 @default.
• W2780680405 hasConceptScore W2780680405C530470458 @default.
• W2780680405 hasConceptScore W2780680405C61511704 @default.
• W2780680405 hasConceptScore W2780680405C71924100 @default.
• W2780680405 hasConceptScore W2780680405C99454951 @default.
• W2780680405 hasIssue "2" @default.
• W2780680405 hasLocation W27806804051 @default.
• W2780680405 hasLocation W27806804052 @default.
• W2780680405 hasOpenAccess W2780680405 @default.
• W2780680405 hasPrimaryLocation W27806804051 @default.
• W2780680405 hasRelatedWork W2016516402 @default.
• W2780680405 hasRelatedWork W2041877114 @default.
• W2780680405 hasRelatedWork W2109596058 @default.
• W2780680405 hasRelatedWork W2268554969 @default.
• W2780680405 hasRelatedWork W2411001056 @default.
• W2780680405 hasRelatedWork W2513801107 @default.
• W2780680405 hasRelatedWork W2782884957 @default.
• W2780680405 hasRelatedWork W2803147610 @default.
• W2780680405 hasRelatedWork W4287730148 @default.
• W2780680405 hasRelatedWork W4292580266 @default.
• W2780680405 hasVolume "287" @default.

• next